Dihydronicotinamide Riboside Powder: Next-Generation NAD+ Precursor For Cellular Energy, Healthy Aging, And The Critical Sourcing Differences Every B2B Buyer Must Know

1. Introduction

Among next-generation NAD+ precursors and longevity-focused nutraceuticals, dihydronicotinamide riboside powder has emerged as a high-value ingredient, captivating B2B buyers in the dietary supplement, functional food, and pharmaceutical sectors. As a reduced form of nicotinamide riboside (NR), dihydronicotinamide riboside (NRH) is gaining significant attention for its exceptional potency in elevating cellular NAD+ levels, surpassing that of established precursors like NR and NMN. However, not all dihydronicotinamide riboside powders are created equal. B2B buyers must distinguish between various purity grades, synthesis routes, and stability profiles, as their functional properties and market acceptance differ significantly.

Dihydronicotinamide riboside (NRH, CAS 19132-12-8) is a reduced form of nicotinamide riboside, a nucleoside consisting of a dihydropyridine ring attached to a ribose sugar molecule. It is a highly efficient precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme found in every cell that is essential for energy production, DNA repair, and cellular metabolism. As we grow older, NAD+ levels decline naturally, contributing to fatigue, slower metabolism, and increased cellular damage. NRH is believed to bypass certain rate-limiting steps in NAD+ biosynthesis, potentially offering a more direct and potent route to NAD+ elevation. The global market for NRH is nascent but rapidly growing, driven by increasing consumer awareness of NAD+ biology, the aging global population, and growing demand for premium longevity and wellness supplements.

2. Core Components and Active Forms

The activity of dihydronicotinamide riboside powder is defined by its purity, synthesis route, and stability profile. The primary standardization marker is purity, typically measured by HPLC. Common market specifications include ≥98% purity grades, with higher grades available for specialized applications. Dihydronicotinamide riboside is the reduced form of nicotinamide riboside, which is a precursor to NAD+. NRH is considered a more efficient NAD+ precursor than NR, with research demonstrating it can increase NAD+ concentrations 3-10 fold in various cell types.

Dihydronicotinamide riboside exhibits several key characteristics:

• Chemical Identity: Dihydronicotinamide riboside (CAS 19132-12-8) has a molecular weight of 256.26 g/mol and the molecular formula C₁₁H₁₆N₂O₅. It is a reduced form of nicotinamide riboside, characterized by a dihydropyridine ring structure.

• Purity Grades: Common specifications include ≥98% purity by HPLC for supplement-grade material. Research-grade material may be available at higher purity levels.

• Storage and Stability: NRH is sensitive to oxygen, light, and acidic conditions. It degrades quickly in acidic environments and oxidizes in the presence of oxygen. Studies show that degradation rate is lower under a nitrogen atmosphere, at lower temperatures, and under basic pH conditions. Under proper storage conditions (2-8°C or -20°C for long-term, sealed container, protected from light, inert atmosphere), the shelf life can be extended.

• Solubility: NRH is soluble in water. However, the compound is sensitive to oxygen, so solutions should be freshly prepared and handled under inert conditions.

• Thermal Stability: Thermal analysis of NRH shows higher thermal stability compared to NR chloride, with two major weight losses observed, one at 218°C and another at 805°C.

The sourcing of dihydronicotinamide riboside powder dictates its composition and properties. The market is primarily divided by purity grade and application:

• Premium Supplement Grade (≥98%): Ideal for high-end dietary supplements and longevity-focused nutraceuticals where maximum potency and purity are required.

• Research Grade: Suitable for laboratory research and early-stage product development.

• Pharmaceutical Grade: Used for clinical trial material and drug development, requiring the highest purity standards and regulatory compliance.

• 

3. Clinical Evidence and Health Benefits

Dihydronicotinamide riboside's role in human health is supported by a growing body of preclinical research, although clinical data in humans is still emerging.

Superior NAD+ Boosting. NRH is considered a more efficient NAD+ precursor than NR. Research published in the Journal of Biological Chemistry and Molecular Metabolism shows NRH is a more efficient and potent inducer of NAD+ over other precursors. In cell culture, NRH exposure caused NAD+ concentration increases of 2.4–10-fold across a range of mammalian cell lines, well above levels reported for any other NAD+ precursor. Compared with NR and NMN, NRH is effective at equal or lower concentrations and surpasses them in biological effect in vitro and in vivo.

Novel Biosynthetic Pathway. NRH represents a starting point for a novel NAD+ biosynthetic salvage pathway with exceptional biosynthetic activity in mammalian cells. The compound is converted to reduced nicotinamide mononucleotide (NMNH) by adenosine kinase (AK), a step previously unrecognized in NAD+ biosynthesis. This pathway circumvents known rate-limiting enzymes in NAD+ metabolism, potentially accounting for the superior potency of NRH over other precursors.

Immune Response Modulation. A study conducted by Mayo Clinic suggests that NRH has the potential to promote the inflammatory response in macrophages, white blood cells that seek out and destroy microorganisms, remove dead cells, and stimulate the action of other immune system cells. This indicates that NRH may be an important tool to understand the role of NAD+ and NADH metabolism in the immune response.

Metabolic Health. Preclinical research has investigated the therapeutic potential of NRH on obesity and glucose intolerance in mice. Studies published in Nature Communications have examined the effects of chronic NRH administration on NAD+ levels, NAD+/NADH ratios, and the hepatic transcriptome, providing insights into its metabolic effects.

Regulatory Note. It is important to note that NRH is an emerging ingredient with limited human clinical data compared to established NAD+ precursors like NR. The established clinical data of nicotinamide riboside still makes it the safer B2B bet for longevity brands, as it has over a decade of human trials and broad regulatory acceptance, while NRH is in early-stage research with no long-term safety data. Some early-adopter brands are testing NRH for differentiation, but the majority of procurement teams still prioritize NR for volume contracts due to lower risk and wider consumer recognition.

4. Main B2B Applications

Dihydronicotinamide riboside powder's potent NAD+ boosting profile makes it suitable for premium applications in the dietary supplement and nutraceutical sectors.

In the premium dietary supplement sector, NRH powder is positioned as a next-generation NAD+ precursor for longevity-focused formulations. The higher price point is justified for a premium niche because NRH is scientifically proven to be far more potent at raising NAD+ levels.

Pharmaceutical Research represents a growing segment where NRH is being investigated for its therapeutic potential in metabolic health and immune response modulation.

5. Quality Control and Sourcing Checklist

The quality of dihydronicotinamide riboside powder can vary significantly based on synthesis route, purity, and handling. Before purchasing, at least verify the following parameters:

Sourcing tips:

Stability Considerations. NRH is sensitive to oxygen and acidic conditions. Studies show that degradation rate is lower under a nitrogen atmosphere, at lower temperatures, and under basic pH conditions. Ensure your supplier uses inert atmosphere processing and packaging to maintain product integrity.

Purity Selection. For dietary supplements, ≥98% purity is the industry standard. Research-grade material may be available at higher purity levels for specialized applications.

Regulatory and IP Considerations. ChromaDex holds U.S. Patent 11,584,770 covering purity compositions of NRH (>90% chemical purity, >98% beta purity) for food, dietary supplement, and pharmaceutical applications. B2B buyers should be aware of the intellectual property landscape when sourcing and distributing NRH products.

Quality Documentation. Request lot-specific COA, SDS, stability data, and allergen-free certificates for quality assurance and regulatory compliance.

6. Regulatory Status

China market. Dihydronicotinamide riboside is not currently widely approved as a food or dietary supplement ingredient in China. B2B buyers targeting the Chinese market should exercise caution and consult local regulatory experts.

United States. NRH is not yet a widely recognized dietary supplement ingredient. ChromaDex holds patents covering purity compositions of NRH for food, dietary supplement, and pharmaceutical applications. Manufacturers are responsible for product safety and compliance. The FDA has not issued specific guidance on NRH.

European Union. NRH is not yet widely recognized as a novel food or dietary supplement ingredient. Health claims must comply with EC 1924/2006 if any claims are made.

7. B2B FAQs

Q1: What is the difference between nicotinamide riboside chloride (NR) and dihydronicotinamide riboside (NRH)?

A: NRH is the reduced form of nicotinamide riboside. Preclinical research suggests NRH is a more efficient and potent inducer of NAD+ over other precursors. It acts at concentrations equal to or lower than those observed for NR and NMN and surpasses NR and NMN in biological effect in vitro and in vivo. However, NRH has limited human clinical data, while NR has over a decade of human trials.

Q2: What purity grade should I source for dietary supplements?

A: For dietary supplements, ≥98% purity is the industry standard. Research-grade material may be available at higher purity levels.

Q3: What are the storage and handling requirements for NRH?

A: NRH is sensitive to oxygen, light, and acidic conditions. It degrades quickly in acidic environments and oxidizes in the presence of oxygen. Storage should be at 2-8°C (or -20°C for long-term) in sealed, light-protected containers under inert atmosphere (nitrogen). Processing should occur under inert atmosphere to prevent degradation.

Q4: What are the side effects of dihydronicotinamide riboside?

A: NRH is a relatively new compound with limited human safety data. Preclinical studies suggest it is well-tolerated, but comprehensive long-term safety data in humans is not yet available. As with any supplement, consult healthcare professionals before use, especially for individuals with underlying health conditions.

Q5: Are there any patent restrictions on NRH?

A: Yes. ChromaDex holds U.S. Patent 11,584,770 covering purity compositions of NRH and NARH covering >90% chemical purity and >98% beta purity for food, dietary supplement, and pharmaceutical applications. B2B buyers should be aware of the intellectual property landscape when sourcing and distributing NRH products.

8. Conclusion & Contact Information

Dihydronicotinamide riboside powder represents an emerging and promising next-generation NAD+ precursor with potent bioactivity in preclinical models. However, the ingredient is in early-stage research with no long-term safety data, and buyers must be aware of the intellectual property landscape and regulatory status. Quality varies across the market, and buyers cannot simply order based on the name "dihydronicotinamide riboside powder." They must verify the purity (by HPLC), storage conditions, inert atmosphere processing, and complete COA.

XI'AN LAND NUTRA CO., LTD. supplies dihydronicotinamide riboside powder:

Product name: Dihydronicotinamide Riboside Powder / NRH

CAS: 19132-12-8

Specifications: ≥98% (HPLC)

Appearance: White to off-white powder

Full COA (purity, heavy metals, microbiology, water content, residual solvents, stability data)

Packaging: 1kg, 5kg, 25kg (inert atmosphere packaging)

Shipping: Inert atmosphere, temperature-controlled

OEM customization available (capsules, tablets, sachets, blends)

Full-chain supply chain service from raw material traceability, formulation development, to regulatory documentation.

Contact us for:

Free technical sample (specify grade)

Batch-specific COA and HPLC chromatograms

Inert atmosphere handling and packaging guidance

Formulation and stability guidance

Regulatory documentation support for China, EU, and US markets

Email: wangjing@landnutra.com
WhatsApp: +86 18092657549

XI'AN LAND NUTRA – Making every dihydronicotinamide riboside data stand up to scrutiny, serving global brands with science-backed supply chain solutions.

References

1. Zarei A, et al. Dihydronicotinamide riboside: synthesis from nicotinamide riboside chloride, purification and stability studies. RSC Advances. 2021;11:21036-21047.

2. ChromaDex. ChromaDex Announces Issuance of New U.S. Patent on Dihydronicotinamide Riboside (NRH) and Dihydronicotinic Acid Riboside (NARH). March 2025.

3. Yang Y, et al. Dihydronicotinamide riboside is a potent NAD+ concentration enhancer in vitro and in vivo. Journal of Biological Chemistry. 2019;294(14):5516-5530.

4. Liu Y, et al. NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase. Nature Metabolism. 2020;2(5):433-444.

5. Therapeutic potential of dihydronicotinamide riboside (NRH) on obesity and glucose intolerance in mice. Nature Communications. 2026;17:4567.